Digital Health Valuation Multiples
Explore private market Digital Health valuation multiples with benchmarks structured by stage and region. Updated quarterly.
Digital Health
Digital Health companies develop software, platforms, and connected devices that improve healthcare delivery, patient outcomes, and clinical workflows. Private market valuations reflect regulatory pathway clarity, clinical evidence, health system adoption rates, and the ability to demonstrate measurable improvements in care quality or cost efficiency.
The category spans telehealth platforms, remote patient monitoring, clinical decision support, electronic health records, and wellness applications. DealMatrix tracks valuation dynamics across 7 funding stages and all major global regions, updated every quarter.
Sector
Digital Health
Health & Life Sciences
Sector tracked since
2006
19+ years of data
EV/SALES & EV/EBITDA ACROSS
6 Regions · 7 Stages
Modelled independently via proprietary econometric approach
UPDATE FREQUENCY
Quarterly
Data updates & model improvement
Digital Health Valuation Multiples
Select a region and funding stage to preview how Digital Health companies are valued in private markets. Full data available on the platform.
The Venionaire DealMatrix Multiples Model
DealMatrix multiples are derived through a five-step model combining public capital market comparables, proprietary VC/PE/M&A transaction data, and macroeconomic indicators.
The model produces three components: The reported public multiple, the model-predicted multiple, and the lower bound predicted multiple averaged into the DealMatrix Composite, then adjusted for region and funding stage. The methodology follows the IPEV Guidelines 2025.
Pet Love Boom Fuels Lassie’s $75m Series C as It Moves to Own the Future of Pet Care in Europe
raised
Valuation
VisionHealth Raises EUR 1.5M in Funding
raised
Valuation
Eden Health Raises USD 60M in Series C Funding
raised
Valuation
Telemedico gets USD 6.6M to grow the reach of its digital health SaaS
raised
Valuation
Six-digit follow-up investment for health startup myBioma
raised
Valuation
Health & Life Sciences
MedTech
